About Lucid Diagnostics, Inc. 
Lucid Diagnostics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 13 Schemes (15.01%)
Foreign Institutions
Held by 9 Foreign Institutions (0.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
Pharmaceuticals & Biotechnology
USD 133 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.63
-605.95%
16.90






